nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulindac—SLC22A6—Furosemide—dilated cardiomyopathy	0.165	0.54	CbGbCtD
Sulindac—ALB—Furosemide—dilated cardiomyopathy	0.141	0.46	CbGbCtD
Sulindac—Gastrointestinal cramps—Lisinopril—dilated cardiomyopathy	0.0641	0.207	CcSEcCtD
Sulindac—PTGDR2—heart—dilated cardiomyopathy	0.0138	0.146	CbGeAlD
Sulindac—AKR1B1—cardiac ventricle—dilated cardiomyopathy	0.0112	0.118	CbGeAlD
Sulindac—AKR1B1—myocardium—dilated cardiomyopathy	0.0105	0.111	CbGeAlD
Sulindac—MAPK3—cardiac ventricle—dilated cardiomyopathy	0.00811	0.0856	CbGeAlD
Sulindac—MAPK3—myocardium—dilated cardiomyopathy	0.00763	0.0805	CbGeAlD
Sulindac—AKR1B1—heart—dilated cardiomyopathy	0.00735	0.0775	CbGeAlD
Sulindac—AKR1B1—cardiac atrium—dilated cardiomyopathy	0.00628	0.0663	CbGeAlD
Sulindac—PPARD—heart—dilated cardiomyopathy	0.00578	0.0609	CbGeAlD
Sulindac—Hyperkalaemia—Spironolactone—dilated cardiomyopathy	0.00534	0.0172	CcSEcCtD
Sulindac—MAPK3—heart—dilated cardiomyopathy	0.00533	0.0562	CbGeAlD
Sulindac—Gynaecomastia—Spironolactone—dilated cardiomyopathy	0.00486	0.0157	CcSEcCtD
Sulindac—MAPK3—cardiac atrium—dilated cardiomyopathy	0.00455	0.048	CbGeAlD
Sulindac—Nephritis interstitial—Furosemide—dilated cardiomyopathy	0.00438	0.0141	CcSEcCtD
Sulindac—Cholestasis—Furosemide—dilated cardiomyopathy	0.0039	0.0126	CcSEcCtD
Sulindac—Tubulointerstitial nephritis—Furosemide—dilated cardiomyopathy	0.00386	0.0125	CcSEcCtD
Sulindac—Nephrolithiasis—Furosemide—dilated cardiomyopathy	0.00368	0.0119	CcSEcCtD
Sulindac—Toxic epidermal necrolysis—Spironolactone—dilated cardiomyopathy	0.00355	0.0115	CcSEcCtD
Sulindac—Gastritis—Spironolactone—dilated cardiomyopathy	0.00349	0.0113	CcSEcCtD
Sulindac—Eosinophilia—Spironolactone—dilated cardiomyopathy	0.00338	0.0109	CcSEcCtD
Sulindac—Bone marrow depression—Lisinopril—dilated cardiomyopathy	0.00329	0.0106	CcSEcCtD
Sulindac—Hearing impaired—Furosemide—dilated cardiomyopathy	0.00311	0.01	CcSEcCtD
Sulindac—Stevens-Johnson syndrome—Spironolactone—dilated cardiomyopathy	0.00302	0.00973	CcSEcCtD
Sulindac—Renal failure—Spironolactone—dilated cardiomyopathy	0.00299	0.00964	CcSEcCtD
Sulindac—Pleural effusion—Lisinopril—dilated cardiomyopathy	0.0029	0.00935	CcSEcCtD
Sulindac—Agranulocytosis—Spironolactone—dilated cardiomyopathy	0.00284	0.00915	CcSEcCtD
Sulindac—Aplastic anaemia—Furosemide—dilated cardiomyopathy	0.00278	0.00896	CcSEcCtD
Sulindac—Erythema multiforme—Spironolactone—dilated cardiomyopathy	0.00258	0.00833	CcSEcCtD
Sulindac—ALB—heart—dilated cardiomyopathy	0.00254	0.0268	CbGeAlD
Sulindac—Proteinuria—Lisinopril—dilated cardiomyopathy	0.00253	0.00815	CcSEcCtD
Sulindac—CYP1A1—cardiac ventricle—dilated cardiomyopathy	0.00251	0.0265	CbGeAlD
Sulindac—Protein urine present—Lisinopril—dilated cardiomyopathy	0.00249	0.00803	CcSEcCtD
Sulindac—Photosensitivity—Furosemide—dilated cardiomyopathy	0.00245	0.00789	CcSEcCtD
Sulindac—Alopecia—Spironolactone—dilated cardiomyopathy	0.00241	0.00778	CcSEcCtD
Sulindac—Vascular purpura—Furosemide—dilated cardiomyopathy	0.0024	0.00774	CcSEcCtD
Sulindac—Haemolytic anaemia—Furosemide—dilated cardiomyopathy	0.00238	0.00767	CcSEcCtD
Sulindac—Leukocytosis—Lisinopril—dilated cardiomyopathy	0.00236	0.00762	CcSEcCtD
Sulindac—Dermatitis exfoliative—Furosemide—dilated cardiomyopathy	0.00228	0.00734	CcSEcCtD
Sulindac—Purpura—Furosemide—dilated cardiomyopathy	0.00223	0.00719	CcSEcCtD
Sulindac—Ill-defined disorder—Spironolactone—dilated cardiomyopathy	0.00221	0.00711	CcSEcCtD
Sulindac—Hyperkalaemia—Lisinopril—dilated cardiomyopathy	0.00218	0.00703	CcSEcCtD
Sulindac—Malaise—Spironolactone—dilated cardiomyopathy	0.00214	0.00691	CcSEcCtD
Sulindac—Leukopenia—Spironolactone—dilated cardiomyopathy	0.00213	0.00686	CcSEcCtD
Sulindac—PTGS1—myocardium—dilated cardiomyopathy	0.00207	0.0219	CbGeAlD
Sulindac—Discomfort—Spironolactone—dilated cardiomyopathy	0.002	0.00645	CcSEcCtD
Sulindac—Anaphylactic shock—Spironolactone—dilated cardiomyopathy	0.00194	0.00626	CcSEcCtD
Sulindac—Toxic epidermal necrolysis—Furosemide—dilated cardiomyopathy	0.00193	0.00624	CcSEcCtD
Sulindac—Thrombocytopenia—Spironolactone—dilated cardiomyopathy	0.0019	0.00613	CcSEcCtD
Sulindac—Muscular weakness—Furosemide—dilated cardiomyopathy	0.00189	0.00611	CcSEcCtD
Sulindac—Eosinophilia—Furosemide—dilated cardiomyopathy	0.00184	0.00593	CcSEcCtD
Sulindac—Photosensitivity—Lisinopril—dilated cardiomyopathy	0.00183	0.00592	CcSEcCtD
Sulindac—Pancreatitis—Furosemide—dilated cardiomyopathy	0.00182	0.00587	CcSEcCtD
Sulindac—Gastroenteritis—Lisinopril—dilated cardiomyopathy	0.00182	0.00586	CcSEcCtD
Sulindac—Hepatic failure—Lisinopril—dilated cardiomyopathy	0.00179	0.00578	CcSEcCtD
Sulindac—Haemolytic anaemia—Lisinopril—dilated cardiomyopathy	0.00178	0.00576	CcSEcCtD
Sulindac—Somnolence—Spironolactone—dilated cardiomyopathy	0.00172	0.00556	CcSEcCtD
Sulindac—Photosensitivity reaction—Furosemide—dilated cardiomyopathy	0.00169	0.00546	CcSEcCtD
Sulindac—Renal impairment—Lisinopril—dilated cardiomyopathy	0.00169	0.00546	CcSEcCtD
Sulindac—Hyperglycaemia—Furosemide—dilated cardiomyopathy	0.00167	0.0054	CcSEcCtD
Sulindac—Arthritis—Lisinopril—dilated cardiomyopathy	0.00166	0.00535	CcSEcCtD
Sulindac—CYP1A1—heart—dilated cardiomyopathy	0.00165	0.0174	CbGeAlD
Sulindac—Stevens-Johnson syndrome—Furosemide—dilated cardiomyopathy	0.00164	0.00529	CcSEcCtD
Sulindac—Renal failure—Furosemide—dilated cardiomyopathy	0.00163	0.00525	CcSEcCtD
Sulindac—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.0016	0.00516	CcSEcCtD
Sulindac—Sweating—Furosemide—dilated cardiomyopathy	0.00159	0.00512	CcSEcCtD
Sulindac—Agranulocytosis—Furosemide—dilated cardiomyopathy	0.00154	0.00498	CcSEcCtD
Sulindac—Urticaria—Spironolactone—dilated cardiomyopathy	0.00154	0.00497	CcSEcCtD
Sulindac—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.00153	0.00495	CcSEcCtD
Sulindac—Toxic epidermal necrolysis—Lisinopril—dilated cardiomyopathy	0.00145	0.00468	CcSEcCtD
Sulindac—PTGS1—heart—dilated cardiomyopathy	0.00145	0.0153	CbGeAlD
Sulindac—Visual impairment—Furosemide—dilated cardiomyopathy	0.00143	0.00462	CcSEcCtD
Sulindac—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.00143	0.00461	CcSEcCtD
Sulindac—Gastritis—Lisinopril—dilated cardiomyopathy	0.00143	0.0046	CcSEcCtD
Sulindac—CYP1A1—cardiac atrium—dilated cardiomyopathy	0.00141	0.0149	CbGeAlD
Sulindac—Erythema multiforme—Furosemide—dilated cardiomyopathy	0.0014	0.00453	CcSEcCtD
Sulindac—Tinnitus—Furosemide—dilated cardiomyopathy	0.00138	0.00447	CcSEcCtD
Sulindac—PTGS2—heart—dilated cardiomyopathy	0.00138	0.0146	CbGeAlD
Sulindac—Eosinophilia—Lisinopril—dilated cardiomyopathy	0.00138	0.00445	CcSEcCtD
Sulindac—Pruritus—Spironolactone—dilated cardiomyopathy	0.00137	0.00443	CcSEcCtD
Sulindac—Bronchospasm—Lisinopril—dilated cardiomyopathy	0.00137	0.00442	CcSEcCtD
Sulindac—Pancreatitis—Lisinopril—dilated cardiomyopathy	0.00137	0.0044	CcSEcCtD
Sulindac—Sweating increased—Lisinopril—dilated cardiomyopathy	0.00136	0.00437	CcSEcCtD
Sulindac—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.00133	0.00428	CcSEcCtD
Sulindac—Arrhythmia—Furosemide—dilated cardiomyopathy	0.00133	0.00428	CcSEcCtD
Sulindac—Pancytopenia—Lisinopril—dilated cardiomyopathy	0.00132	0.00427	CcSEcCtD
Sulindac—Dysuria—Lisinopril—dilated cardiomyopathy	0.0013	0.0042	CcSEcCtD
Sulindac—Neutropenia—Lisinopril—dilated cardiomyopathy	0.0013	0.0042	CcSEcCtD
Sulindac—Dizziness—Spironolactone—dilated cardiomyopathy	0.00128	0.00414	CcSEcCtD
Sulindac—Flatulence—Furosemide—dilated cardiomyopathy	0.00127	0.00411	CcSEcCtD
Sulindac—Photosensitivity reaction—Lisinopril—dilated cardiomyopathy	0.00127	0.0041	CcSEcCtD
Sulindac—Dysgeusia—Furosemide—dilated cardiomyopathy	0.00127	0.00408	CcSEcCtD
Sulindac—Hyperglycaemia—Lisinopril—dilated cardiomyopathy	0.00126	0.00405	CcSEcCtD
Sulindac—Pneumonia—Lisinopril—dilated cardiomyopathy	0.00125	0.00403	CcSEcCtD
Sulindac—Depression—Lisinopril—dilated cardiomyopathy	0.00124	0.00399	CcSEcCtD
Sulindac—PTGS1—cardiac atrium—dilated cardiomyopathy	0.00124	0.0131	CbGeAlD
Sulindac—Vomiting—Spironolactone—dilated cardiomyopathy	0.00123	0.00398	CcSEcCtD
Sulindac—Stevens-Johnson syndrome—Lisinopril—dilated cardiomyopathy	0.00123	0.00397	CcSEcCtD
Sulindac—Rash—Spironolactone—dilated cardiomyopathy	0.00122	0.00394	CcSEcCtD
Sulindac—Dermatitis—Spironolactone—dilated cardiomyopathy	0.00122	0.00394	CcSEcCtD
Sulindac—Renal failure—Lisinopril—dilated cardiomyopathy	0.00122	0.00394	CcSEcCtD
Sulindac—Vision blurred—Furosemide—dilated cardiomyopathy	0.00122	0.00393	CcSEcCtD
Sulindac—Neuropathy peripheral—Lisinopril—dilated cardiomyopathy	0.00122	0.00393	CcSEcCtD
Sulindac—Headache—Spironolactone—dilated cardiomyopathy	0.00122	0.00392	CcSEcCtD
Sulindac—Jaundice—Lisinopril—dilated cardiomyopathy	0.00121	0.0039	CcSEcCtD
Sulindac—Anaemia—Furosemide—dilated cardiomyopathy	0.0012	0.00385	CcSEcCtD
Sulindac—Sweating—Lisinopril—dilated cardiomyopathy	0.00119	0.00384	CcSEcCtD
Sulindac—Haematuria—Lisinopril—dilated cardiomyopathy	0.00118	0.00382	CcSEcCtD
Sulindac—Epistaxis—Lisinopril—dilated cardiomyopathy	0.00117	0.00378	CcSEcCtD
Sulindac—Vertigo—Furosemide—dilated cardiomyopathy	0.00116	0.00375	CcSEcCtD
Sulindac—Agranulocytosis—Lisinopril—dilated cardiomyopathy	0.00116	0.00374	CcSEcCtD
Sulindac—Leukopenia—Furosemide—dilated cardiomyopathy	0.00116	0.00373	CcSEcCtD
Sulindac—Nausea—Spironolactone—dilated cardiomyopathy	0.00115	0.00372	CcSEcCtD
Sulindac—Hepatitis—Lisinopril—dilated cardiomyopathy	0.00111	0.00359	CcSEcCtD
Sulindac—Anaphylactic shock—Furosemide—dilated cardiomyopathy	0.00106	0.0034	CcSEcCtD
Sulindac—Erythema multiforme—Lisinopril—dilated cardiomyopathy	0.00105	0.0034	CcSEcCtD
Sulindac—Tinnitus—Lisinopril—dilated cardiomyopathy	0.00104	0.00335	CcSEcCtD
Sulindac—Shock—Furosemide—dilated cardiomyopathy	0.00104	0.00335	CcSEcCtD
Sulindac—Flushing—Lisinopril—dilated cardiomyopathy	0.00103	0.00334	CcSEcCtD
Sulindac—Thrombocytopenia—Furosemide—dilated cardiomyopathy	0.00103	0.00333	CcSEcCtD
Sulindac—Hyperhidrosis—Furosemide—dilated cardiomyopathy	0.00102	0.00329	CcSEcCtD
Sulindac—Anorexia—Furosemide—dilated cardiomyopathy	0.00101	0.00324	CcSEcCtD
Sulindac—Chills—Lisinopril—dilated cardiomyopathy	0.001	0.00323	CcSEcCtD
Sulindac—Arrhythmia—Lisinopril—dilated cardiomyopathy	0.000996	0.00321	CcSEcCtD
Sulindac—Hypotension—Furosemide—dilated cardiomyopathy	0.000986	0.00318	CcSEcCtD
Sulindac—Alopecia—Lisinopril—dilated cardiomyopathy	0.000985	0.00318	CcSEcCtD
Sulindac—Flatulence—Lisinopril—dilated cardiomyopathy	0.000956	0.00308	CcSEcCtD
Sulindac—Tension—Lisinopril—dilated cardiomyopathy	0.000952	0.00307	CcSEcCtD
Sulindac—Dysgeusia—Lisinopril—dilated cardiomyopathy	0.00095	0.00306	CcSEcCtD
Sulindac—Paraesthesia—Furosemide—dilated cardiomyopathy	0.000948	0.00306	CcSEcCtD
Sulindac—Nervousness—Lisinopril—dilated cardiomyopathy	0.000942	0.00304	CcSEcCtD
Sulindac—Somnolence—Furosemide—dilated cardiomyopathy	0.000938	0.00303	CcSEcCtD
Sulindac—Decreased appetite—Furosemide—dilated cardiomyopathy	0.000917	0.00296	CcSEcCtD
Sulindac—Vision blurred—Lisinopril—dilated cardiomyopathy	0.000914	0.00295	CcSEcCtD
Sulindac—Fatigue—Furosemide—dilated cardiomyopathy	0.00091	0.00293	CcSEcCtD
Sulindac—Constipation—Furosemide—dilated cardiomyopathy	0.000902	0.00291	CcSEcCtD
Sulindac—Ill-defined disorder—Lisinopril—dilated cardiomyopathy	0.0009	0.0029	CcSEcCtD
Sulindac—Anaemia—Lisinopril—dilated cardiomyopathy	0.000897	0.00289	CcSEcCtD
Sulindac—Angioedema—Lisinopril—dilated cardiomyopathy	0.000887	0.00286	CcSEcCtD
Sulindac—Malaise—Lisinopril—dilated cardiomyopathy	0.000875	0.00282	CcSEcCtD
Sulindac—Vertigo—Lisinopril—dilated cardiomyopathy	0.000872	0.00281	CcSEcCtD
Sulindac—Syncope—Lisinopril—dilated cardiomyopathy	0.00087	0.00281	CcSEcCtD
Sulindac—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.00087	0.00281	CcSEcCtD
Sulindac—Leukopenia—Lisinopril—dilated cardiomyopathy	0.000868	0.0028	CcSEcCtD
Sulindac—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.000863	0.00278	CcSEcCtD
Sulindac—Palpitations—Lisinopril—dilated cardiomyopathy	0.000857	0.00277	CcSEcCtD
Sulindac—Loss of consciousness—Lisinopril—dilated cardiomyopathy	0.000853	0.00275	CcSEcCtD
Sulindac—Urticaria—Furosemide—dilated cardiomyopathy	0.000838	0.0027	CcSEcCtD
Sulindac—Body temperature increased—Furosemide—dilated cardiomyopathy	0.000834	0.00269	CcSEcCtD
Sulindac—Chest pain—Lisinopril—dilated cardiomyopathy	0.000826	0.00266	CcSEcCtD
Sulindac—Myalgia—Lisinopril—dilated cardiomyopathy	0.000826	0.00266	CcSEcCtD
Sulindac—Arthralgia—Lisinopril—dilated cardiomyopathy	0.000826	0.00266	CcSEcCtD
Sulindac—Discomfort—Lisinopril—dilated cardiomyopathy	0.000816	0.00263	CcSEcCtD
Sulindac—Anaphylactic shock—Lisinopril—dilated cardiomyopathy	0.000792	0.00255	CcSEcCtD
Sulindac—Oedema—Lisinopril—dilated cardiomyopathy	0.000792	0.00255	CcSEcCtD
Sulindac—Shock—Lisinopril—dilated cardiomyopathy	0.000779	0.00251	CcSEcCtD
Sulindac—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.000778	0.00251	CcSEcCtD
Sulindac—Thrombocytopenia—Lisinopril—dilated cardiomyopathy	0.000775	0.0025	CcSEcCtD
Sulindac—Tachycardia—Lisinopril—dilated cardiomyopathy	0.000773	0.00249	CcSEcCtD
Sulindac—Hyperhidrosis—Lisinopril—dilated cardiomyopathy	0.000765	0.00247	CcSEcCtD
Sulindac—Asthenia—Furosemide—dilated cardiomyopathy	0.000757	0.00244	CcSEcCtD
Sulindac—Anorexia—Lisinopril—dilated cardiomyopathy	0.000755	0.00243	CcSEcCtD
Sulindac—Pruritus—Furosemide—dilated cardiomyopathy	0.000747	0.00241	CcSEcCtD
Sulindac—Hypotension—Lisinopril—dilated cardiomyopathy	0.00074	0.00239	CcSEcCtD
Sulindac—Diarrhoea—Furosemide—dilated cardiomyopathy	0.000722	0.00233	CcSEcCtD
Sulindac—Musculoskeletal discomfort—Lisinopril—dilated cardiomyopathy	0.000721	0.00233	CcSEcCtD
Sulindac—Insomnia—Lisinopril—dilated cardiomyopathy	0.000716	0.00231	CcSEcCtD
Sulindac—Paraesthesia—Lisinopril—dilated cardiomyopathy	0.000711	0.00229	CcSEcCtD
Sulindac—Dyspnoea—Lisinopril—dilated cardiomyopathy	0.000706	0.00228	CcSEcCtD
Sulindac—Somnolence—Lisinopril—dilated cardiomyopathy	0.000704	0.00227	CcSEcCtD
Sulindac—Dizziness—Furosemide—dilated cardiomyopathy	0.000698	0.00225	CcSEcCtD
Sulindac—Dyspepsia—Lisinopril—dilated cardiomyopathy	0.000697	0.00225	CcSEcCtD
Sulindac—Decreased appetite—Lisinopril—dilated cardiomyopathy	0.000688	0.00222	CcSEcCtD
Sulindac—Fatigue—Lisinopril—dilated cardiomyopathy	0.000683	0.0022	CcSEcCtD
Sulindac—Constipation—Lisinopril—dilated cardiomyopathy	0.000677	0.00218	CcSEcCtD
Sulindac—Vomiting—Furosemide—dilated cardiomyopathy	0.000671	0.00216	CcSEcCtD
Sulindac—Rash—Furosemide—dilated cardiomyopathy	0.000665	0.00215	CcSEcCtD
Sulindac—Dermatitis—Furosemide—dilated cardiomyopathy	0.000665	0.00214	CcSEcCtD
Sulindac—Headache—Furosemide—dilated cardiomyopathy	0.000661	0.00213	CcSEcCtD
Sulindac—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.000652	0.0021	CcSEcCtD
Sulindac—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	0.000647	0.00209	CcSEcCtD
Sulindac—Urticaria—Lisinopril—dilated cardiomyopathy	0.000629	0.00203	CcSEcCtD
Sulindac—Nausea—Furosemide—dilated cardiomyopathy	0.000627	0.00202	CcSEcCtD
Sulindac—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.000626	0.00202	CcSEcCtD
Sulindac—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.000583	0.00188	CcSEcCtD
Sulindac—Asthenia—Lisinopril—dilated cardiomyopathy	0.000568	0.00183	CcSEcCtD
Sulindac—Pruritus—Lisinopril—dilated cardiomyopathy	0.00056	0.00181	CcSEcCtD
Sulindac—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.000542	0.00175	CcSEcCtD
Sulindac—Dizziness—Lisinopril—dilated cardiomyopathy	0.000524	0.00169	CcSEcCtD
Sulindac—Vomiting—Lisinopril—dilated cardiomyopathy	0.000503	0.00162	CcSEcCtD
Sulindac—Rash—Lisinopril—dilated cardiomyopathy	0.000499	0.00161	CcSEcCtD
Sulindac—Dermatitis—Lisinopril—dilated cardiomyopathy	0.000499	0.00161	CcSEcCtD
Sulindac—Headache—Lisinopril—dilated cardiomyopathy	0.000496	0.0016	CcSEcCtD
Sulindac—Nausea—Lisinopril—dilated cardiomyopathy	0.00047	0.00152	CcSEcCtD
Sulindac—PTGDR2—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000249	0.000858	CbGpPWpGaD
Sulindac—MAPK3—Integrated Pancreatic Cancer Pathway—RAC1—dilated cardiomyopathy	0.000246	0.00085	CbGpPWpGaD
Sulindac—MAPK3—Signaling by VEGF—RAF1—dilated cardiomyopathy	0.000245	0.000846	CbGpPWpGaD
Sulindac—MAPK3—Signaling by Insulin receptor—RAF1—dilated cardiomyopathy	0.000243	0.00084	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.000241	0.000831	CbGpPWpGaD
Sulindac—ALB—Response to elevated platelet cytosolic Ca2+—CD36—dilated cardiomyopathy	0.00024	0.000829	CbGpPWpGaD
Sulindac—ALB—Selenium Micronutrient Network—GPX1—dilated cardiomyopathy	0.00024	0.000828	CbGpPWpGaD
Sulindac—PTGDR2—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000237	0.00082	CbGpPWpGaD
Sulindac—PPARD—Gene Expression—NPPA—dilated cardiomyopathy	0.000237	0.000817	CbGpPWpGaD
Sulindac—AKR1B1—Metabolism—AGT—dilated cardiomyopathy	0.000236	0.000816	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000235	0.000813	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000235	0.000813	CbGpPWpGaD
Sulindac—ALB—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.000233	0.000805	CbGpPWpGaD
Sulindac—MAPK3—Platelet activation, signaling and aggregation—CD36—dilated cardiomyopathy	0.000232	0.000802	CbGpPWpGaD
Sulindac—MAPK3—PDGFR-beta signaling pathway—RAF1—dilated cardiomyopathy	0.000229	0.000791	CbGpPWpGaD
Sulindac—MAPK3—Developmental Biology—PSEN2—dilated cardiomyopathy	0.000229	0.00079	CbGpPWpGaD
Sulindac—MAPK3—Cell Cycle—TMPO—dilated cardiomyopathy	0.000226	0.000782	CbGpPWpGaD
Sulindac—PTGDR2—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000226	0.000779	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways in Glioblastoma—EGFR—dilated cardiomyopathy	0.00022	0.00076	CbGpPWpGaD
Sulindac—PPARD—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	0.000219	0.000757	CbGpPWpGaD
Sulindac—ALB—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.000219	0.000757	CbGpPWpGaD
Sulindac—MAPK3—Platelet activation, signaling and aggregation—RAC1—dilated cardiomyopathy	0.000219	0.000756	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000219	0.000756	CbGpPWpGaD
Sulindac—MAPK3—Cellular responses to stress—SOD2—dilated cardiomyopathy	0.000217	0.000749	CbGpPWpGaD
Sulindac—MAPK3—Alzheimers Disease—TNF—dilated cardiomyopathy	0.000216	0.000746	CbGpPWpGaD
Sulindac—PTGDR2—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000216	0.000745	CbGpPWpGaD
Sulindac—PTGS2—Spinal Cord Injury—RAC1—dilated cardiomyopathy	0.000215	0.000743	CbGpPWpGaD
Sulindac—CYP1A1—PPARA activates gene expression—CD36—dilated cardiomyopathy	0.000214	0.00074	CbGpPWpGaD
Sulindac—MAPK3—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—dilated cardiomyopathy	0.000214	0.000739	CbGpPWpGaD
Sulindac—PPARD—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	0.000214	0.000737	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000212	0.000732	CbGpPWpGaD
Sulindac—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CD36—dilated cardiomyopathy	0.00021	0.000724	CbGpPWpGaD
Sulindac—MAPK3—Signaling by SCF-KIT—RAF1—dilated cardiomyopathy	0.000208	0.000718	CbGpPWpGaD
Sulindac—MAPK3—Cell Cycle, Mitotic—LMNA—dilated cardiomyopathy	0.000208	0.000718	CbGpPWpGaD
Sulindac—PTGS2—Aryl Hydrocarbon Receptor—EGFR—dilated cardiomyopathy	0.000208	0.000718	CbGpPWpGaD
Sulindac—MAPK3—Cellular responses to stress—GPX1—dilated cardiomyopathy	0.000207	0.000715	CbGpPWpGaD
Sulindac—MAPK3—MicroRNAs in cardiomyocyte hypertrophy—TNF—dilated cardiomyopathy	0.000206	0.00071	CbGpPWpGaD
Sulindac—MAPK3—BDNF signaling pathway—RAF1—dilated cardiomyopathy	0.000205	0.000706	CbGpPWpGaD
Sulindac—MAPK3—Axon guidance—ITGB1—dilated cardiomyopathy	0.000201	0.000693	CbGpPWpGaD
Sulindac—MAPK3—Downstream signaling of activated FGFR—RAF1—dilated cardiomyopathy	0.000199	0.000687	CbGpPWpGaD
Sulindac—MAPK3—Regulation of Actin Cytoskeleton—RAF1—dilated cardiomyopathy	0.000199	0.000687	CbGpPWpGaD
Sulindac—PTGS2—Aryl Hydrocarbon Receptor—TNF—dilated cardiomyopathy	0.000198	0.000684	CbGpPWpGaD
Sulindac—MAPK3—Signaling by ERBB4—RAF1—dilated cardiomyopathy	0.000196	0.000676	CbGpPWpGaD
Sulindac—MAPK3—L1CAM interactions—EGFR—dilated cardiomyopathy	0.000194	0.00067	CbGpPWpGaD
Sulindac—CYP1A1—PPARA activates gene expression—AGT—dilated cardiomyopathy	0.000193	0.000666	CbGpPWpGaD
Sulindac—MAPK3—Gene Expression—NR3C2—dilated cardiomyopathy	0.000192	0.000665	CbGpPWpGaD
Sulindac—PPARD—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	0.000192	0.000664	CbGpPWpGaD
Sulindac—MAPK3—TNF alpha Signaling Pathway—TNF—dilated cardiomyopathy	0.000191	0.00066	CbGpPWpGaD
Sulindac—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—AGT—dilated cardiomyopathy	0.000189	0.000652	CbGpPWpGaD
Sulindac—MAPK3—Insulin Signaling—RAF1—dilated cardiomyopathy	0.000188	0.000649	CbGpPWpGaD
Sulindac—MAPK3—Downstream signal transduction—RAF1—dilated cardiomyopathy	0.000187	0.000646	CbGpPWpGaD
Sulindac—MAPK3—Signaling by FGFR—RAF1—dilated cardiomyopathy	0.000186	0.000643	CbGpPWpGaD
Sulindac—MAPK3—Cell Cycle—LMNA—dilated cardiomyopathy	0.000186	0.000642	CbGpPWpGaD
Sulindac—MAPK3—Signaling by ERBB2—RAF1—dilated cardiomyopathy	0.000185	0.00064	CbGpPWpGaD
Sulindac—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—dilated cardiomyopathy	0.000185	0.000639	CbGpPWpGaD
Sulindac—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—dilated cardiomyopathy	0.000184	0.000637	CbGpPWpGaD
Sulindac—CYP1A1—Aryl Hydrocarbon Receptor—EGFR—dilated cardiomyopathy	0.000184	0.000637	CbGpPWpGaD
Sulindac—MAPK3—DAP12 signaling—RAF1—dilated cardiomyopathy	0.000184	0.000637	CbGpPWpGaD
Sulindac—ALB—Hemostasis—TTN—dilated cardiomyopathy	0.000183	0.00063	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000181	0.000625	CbGpPWpGaD
Sulindac—MAPK3—MAPK Signaling Pathway—RAF1—dilated cardiomyopathy	0.000181	0.000624	CbGpPWpGaD
Sulindac—MAPK3—ErbB1 downstream signaling—EGFR—dilated cardiomyopathy	0.000181	0.000624	CbGpPWpGaD
Sulindac—MAPK3—Signaling by NGF—RAC1—dilated cardiomyopathy	0.000178	0.000615	CbGpPWpGaD
Sulindac—MAPK3—Toll-like Receptor Signaling Pathway—TNF—dilated cardiomyopathy	0.000176	0.000608	CbGpPWpGaD
Sulindac—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—dilated cardiomyopathy	0.000176	0.000607	CbGpPWpGaD
Sulindac—CYP1A1—Aryl Hydrocarbon Receptor—TNF—dilated cardiomyopathy	0.000176	0.000607	CbGpPWpGaD
Sulindac—MAPK3—Fc epsilon receptor (FCERI) signaling—RAF1—dilated cardiomyopathy	0.000173	0.000599	CbGpPWpGaD
Sulindac—MAPK3—DAP12 interactions—RAF1—dilated cardiomyopathy	0.000173	0.000599	CbGpPWpGaD
Sulindac—MAPK3—Signaling by FGFR in disease—RAF1—dilated cardiomyopathy	0.000173	0.000599	CbGpPWpGaD
Sulindac—MAPK3—Signaling by EGFR—RAF1—dilated cardiomyopathy	0.000172	0.000593	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000172	0.000593	CbGpPWpGaD
Sulindac—CYP1A2—Aryl Hydrocarbon Receptor—RAF1—dilated cardiomyopathy	0.000171	0.000592	CbGpPWpGaD
Sulindac—MAPK3—Signaling by EGFR in Cancer—RAF1—dilated cardiomyopathy	0.00017	0.000588	CbGpPWpGaD
Sulindac—MAPK3—Signaling by PDGF—RAF1—dilated cardiomyopathy	0.00017	0.000586	CbGpPWpGaD
Sulindac—MAPK3—Spinal Cord Injury—EGFR—dilated cardiomyopathy	0.000164	0.000568	CbGpPWpGaD
Sulindac—MAPK3—Integrated Pancreatic Cancer Pathway—RAF1—dilated cardiomyopathy	0.000163	0.000563	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.000163	0.000563	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—ANKRD1—dilated cardiomyopathy	0.000162	0.000558	CbGpPWpGaD
Sulindac—MAPK3—Axon guidance—RAC1—dilated cardiomyopathy	0.000161	0.000557	CbGpPWpGaD
Sulindac—ALB—Hemostasis—ACTN2—dilated cardiomyopathy	0.000158	0.000547	CbGpPWpGaD
Sulindac—ALB—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000158	0.000546	CbGpPWpGaD
Sulindac—MAPK3—Spinal Cord Injury—TNF—dilated cardiomyopathy	0.000157	0.000541	CbGpPWpGaD
Sulindac—PTGS2—Integrated Pancreatic Cancer Pathway—FASLG—dilated cardiomyopathy	0.000155	0.000535	CbGpPWpGaD
Sulindac—ALB—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000154	0.000531	CbGpPWpGaD
Sulindac—ALB—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000154	0.000531	CbGpPWpGaD
Sulindac—MAPK3—NGF signalling via TRKA from the plasma membrane—RAF1—dilated cardiomyopathy	0.000154	0.00053	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.000153	0.00053	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—TAZ—dilated cardiomyopathy	0.000152	0.000525	CbGpPWpGaD
Sulindac—PTGDR2—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.00015	0.000517	CbGpPWpGaD
Sulindac—PTGS2—Integrated Pancreatic Cancer Pathway—FAS—dilated cardiomyopathy	0.000149	0.000515	CbGpPWpGaD
Sulindac—MAPK3—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—dilated cardiomyopathy	0.000148	0.000513	CbGpPWpGaD
Sulindac—PTGS1—Selenium Micronutrient Network—TNF—dilated cardiomyopathy	0.000148	0.000512	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000148	0.00051	CbGpPWpGaD
Sulindac—ALB—Vitamin B12 Metabolism—TNF—dilated cardiomyopathy	0.000147	0.000509	CbGpPWpGaD
Sulindac—PTGS2—Integrated Pancreatic Cancer Pathway—RAC1—dilated cardiomyopathy	0.000146	0.000505	CbGpPWpGaD
Sulindac—MAPK3—Platelet activation, signaling and aggregation—RAF1—dilated cardiomyopathy	0.000145	0.000501	CbGpPWpGaD
Sulindac—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—CD36—dilated cardiomyopathy	0.000144	0.000499	CbGpPWpGaD
Sulindac—MAPK3—Developmental Biology—ITGB1—dilated cardiomyopathy	0.000143	0.000494	CbGpPWpGaD
Sulindac—ALB—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000143	0.000493	CbGpPWpGaD
Sulindac—MAPK3—Signaling by SCF-KIT—EGFR—dilated cardiomyopathy	0.000143	0.000493	CbGpPWpGaD
Sulindac—MAPK3—Hemostasis—ITGB1—dilated cardiomyopathy	0.00014	0.000485	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—SDHA—dilated cardiomyopathy	0.000137	0.000475	CbGpPWpGaD
Sulindac—MAPK3—Regulation of toll-like receptor signaling pathway—TNF—dilated cardiomyopathy	0.000137	0.000475	CbGpPWpGaD
Sulindac—MAPK3—Regulation of Actin Cytoskeleton—EGFR—dilated cardiomyopathy	0.000136	0.000471	CbGpPWpGaD
Sulindac—MAPK3—Downstream signaling of activated FGFR—EGFR—dilated cardiomyopathy	0.000136	0.000471	CbGpPWpGaD
Sulindac—ALB—Hemostasis—VCL—dilated cardiomyopathy	0.000135	0.000465	CbGpPWpGaD
Sulindac—MAPK3—Signaling by ERBB4—EGFR—dilated cardiomyopathy	0.000134	0.000464	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000133	0.00046	CbGpPWpGaD
Sulindac—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—AGT—dilated cardiomyopathy	0.00013	0.000449	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—ANKRD1—dilated cardiomyopathy	0.000128	0.000443	CbGpPWpGaD
Sulindac—MAPK3—Downstream signal transduction—EGFR—dilated cardiomyopathy	0.000128	0.000443	CbGpPWpGaD
Sulindac—MAPK3—Signaling by FGFR—EGFR—dilated cardiomyopathy	0.000128	0.000441	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—AGT—dilated cardiomyopathy	0.000127	0.00044	CbGpPWpGaD
Sulindac—MAPK3—Signaling by ERBB2—EGFR—dilated cardiomyopathy	0.000127	0.000439	CbGpPWpGaD
Sulindac—MAPK3—DAP12 signaling—EGFR—dilated cardiomyopathy	0.000126	0.000436	CbGpPWpGaD
Sulindac—MAPK3—MAPK Signaling Pathway—EGFR—dilated cardiomyopathy	0.000124	0.000428	CbGpPWpGaD
Sulindac—MAPK3—Developmental Biology—CD36—dilated cardiomyopathy	0.000122	0.000422	CbGpPWpGaD
Sulindac—MAPK3—Gene Expression—NPPA—dilated cardiomyopathy	0.000121	0.000417	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—TAZ—dilated cardiomyopathy	0.000121	0.000417	CbGpPWpGaD
Sulindac—MAPK3—Cytokine Signaling in Immune system—RAF1—dilated cardiomyopathy	0.00012	0.000415	CbGpPWpGaD
Sulindac—ALB—Folate Metabolism—TNF—dilated cardiomyopathy	0.00012	0.000414	CbGpPWpGaD
Sulindac—MAPK3—Hemostasis—CD36—dilated cardiomyopathy	0.00012	0.000414	CbGpPWpGaD
Sulindac—MAPK3—Signaling by FGFR in disease—EGFR—dilated cardiomyopathy	0.000119	0.000411	CbGpPWpGaD
Sulindac—MAPK3—Fc epsilon receptor (FCERI) signaling—EGFR—dilated cardiomyopathy	0.000119	0.000411	CbGpPWpGaD
Sulindac—MAPK3—DAP12 interactions—EGFR—dilated cardiomyopathy	0.000119	0.000411	CbGpPWpGaD
Sulindac—MAPK3—Signaling by NGF—RAF1—dilated cardiomyopathy	0.000118	0.000408	CbGpPWpGaD
Sulindac—MAPK3—MAPK Signaling Pathway—TNF—dilated cardiomyopathy	0.000118	0.000408	CbGpPWpGaD
Sulindac—MAPK3—Signaling by EGFR—EGFR—dilated cardiomyopathy	0.000118	0.000407	CbGpPWpGaD
Sulindac—PTGS2—Selenium Micronutrient Network—TNF—dilated cardiomyopathy	0.000118	0.000407	CbGpPWpGaD
Sulindac—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—dilated cardiomyopathy	0.000118	0.000406	CbGpPWpGaD
Sulindac—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—dilated cardiomyopathy	0.000118	0.000406	CbGpPWpGaD
Sulindac—MAPK3—Signaling by EGFR in Cancer—EGFR—dilated cardiomyopathy	0.000117	0.000403	CbGpPWpGaD
Sulindac—MAPK3—Signaling by PDGF—EGFR—dilated cardiomyopathy	0.000116	0.000402	CbGpPWpGaD
Sulindac—MAPK3—Developmental Biology—RAC1—dilated cardiomyopathy	0.000115	0.000397	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000114	0.000395	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000114	0.000395	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—ANKRD1—dilated cardiomyopathy	0.000114	0.000393	CbGpPWpGaD
Sulindac—MAPK3—Hemostasis—RAC1—dilated cardiomyopathy	0.000113	0.00039	CbGpPWpGaD
Sulindac—MAPK3—Disease—NPPA—dilated cardiomyopathy	0.000112	0.000387	CbGpPWpGaD
Sulindac—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—dilated cardiomyopathy	0.000112	0.000387	CbGpPWpGaD
Sulindac—CYP1A2—Aryl Hydrocarbon Receptor—TNF—dilated cardiomyopathy	0.000112	0.000387	CbGpPWpGaD
Sulindac—MAPK3—Integrated Pancreatic Cancer Pathway—EGFR—dilated cardiomyopathy	0.000112	0.000386	CbGpPWpGaD
Sulindac—ALB—Platelet activation, signaling and aggregation—CD36—dilated cardiomyopathy	0.000112	0.000386	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—SDHA—dilated cardiomyopathy	0.000109	0.000377	CbGpPWpGaD
Sulindac—MAPK3—Disease—PSEN2—dilated cardiomyopathy	0.000109	0.000375	CbGpPWpGaD
Sulindac—MAPK3—Innate Immune System—CD36—dilated cardiomyopathy	0.000108	0.000372	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—TAZ—dilated cardiomyopathy	0.000107	0.00037	CbGpPWpGaD
Sulindac—MAPK3—Axon guidance—RAF1—dilated cardiomyopathy	0.000107	0.000369	CbGpPWpGaD
Sulindac—MAPK3—Integrated Pancreatic Cancer Pathway—TNF—dilated cardiomyopathy	0.000107	0.000368	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000106	0.000367	CbGpPWpGaD
Sulindac—ALB—Platelet activation, signaling and aggregation—RAC1—dilated cardiomyopathy	0.000105	0.000364	CbGpPWpGaD
Sulindac—MAPK3—NGF signalling via TRKA from the plasma membrane—EGFR—dilated cardiomyopathy	0.000105	0.000364	CbGpPWpGaD
Sulindac—ALB—Metabolism—ANKRD1—dilated cardiomyopathy	0.000104	0.000359	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000103	0.000356	CbGpPWpGaD
Sulindac—PTGDR2—Signaling by GPCR—EGFR—dilated cardiomyopathy	0.000103	0.000354	CbGpPWpGaD
Sulindac—MAPK3—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—dilated cardiomyopathy	0.000102	0.000351	CbGpPWpGaD
Sulindac—MAPK3—Innate Immune System—RAC1—dilated cardiomyopathy	0.000102	0.000351	CbGpPWpGaD
Sulindac—PTGS2—Spinal Cord Injury—EGFR—dilated cardiomyopathy	9.78e-05	0.000338	CbGpPWpGaD
Sulindac—PPARD—Metabolism—GPX1—dilated cardiomyopathy	9.76e-05	0.000337	CbGpPWpGaD
Sulindac—ALB—Metabolism—TAZ—dilated cardiomyopathy	9.76e-05	0.000337	CbGpPWpGaD
Sulindac—PTGS2—Integrated Pancreatic Cancer Pathway—RAF1—dilated cardiomyopathy	9.7e-05	0.000335	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—SDHA—dilated cardiomyopathy	9.69e-05	0.000335	CbGpPWpGaD
Sulindac—ALB—Selenium Micronutrient Network—TNF—dilated cardiomyopathy	9.53e-05	0.000329	CbGpPWpGaD
Sulindac—PPARD—Metabolism—CD36—dilated cardiomyopathy	9.51e-05	0.000328	CbGpPWpGaD
Sulindac—PTGS2—Spinal Cord Injury—TNF—dilated cardiomyopathy	9.31e-05	0.000322	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—RAF1—dilated cardiomyopathy	8.84e-05	0.000305	CbGpPWpGaD
Sulindac—ALB—Metabolism—SDHA—dilated cardiomyopathy	8.83e-05	0.000305	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—AGTR1—dilated cardiomyopathy	8.79e-05	0.000304	CbGpPWpGaD
Sulindac—PPARD—Metabolism—AGT—dilated cardiomyopathy	8.56e-05	0.000296	CbGpPWpGaD
Sulindac—PTGS1—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	8.39e-05	0.00029	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—ADRB2—dilated cardiomyopathy	8.34e-05	0.000288	CbGpPWpGaD
Sulindac—PTGS1—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	8.17e-05	0.000282	CbGpPWpGaD
Sulindac—MAPK3—Signaling by NGF—EGFR—dilated cardiomyopathy	8.1e-05	0.00028	CbGpPWpGaD
Sulindac—MAPK3—Developmental Biology—RAF1—dilated cardiomyopathy	7.63e-05	0.000263	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—PSEN2—dilated cardiomyopathy	7.61e-05	0.000263	CbGpPWpGaD
Sulindac—MAPK3—Hemostasis—RAF1—dilated cardiomyopathy	7.48e-05	0.000258	CbGpPWpGaD
Sulindac—MAPK3—Immune System—ITGB1—dilated cardiomyopathy	7.36e-05	0.000254	CbGpPWpGaD
Sulindac—PTGS1—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	7.35e-05	0.000254	CbGpPWpGaD
Sulindac—MAPK3—Axon guidance—EGFR—dilated cardiomyopathy	7.33e-05	0.000253	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—ANKRD1—dilated cardiomyopathy	7.26e-05	0.000251	CbGpPWpGaD
Sulindac—ALB—Platelet activation, signaling and aggregation—RAF1—dilated cardiomyopathy	6.98e-05	0.000241	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—TAZ—dilated cardiomyopathy	6.83e-05	0.000236	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—CXCL2—dilated cardiomyopathy	6.76e-05	0.000233	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—AGTR2—dilated cardiomyopathy	6.76e-05	0.000233	CbGpPWpGaD
Sulindac—ALB—Hemostasis—ITGB1—dilated cardiomyopathy	6.75e-05	0.000233	CbGpPWpGaD
Sulindac—MAPK3—Innate Immune System—RAF1—dilated cardiomyopathy	6.74e-05	0.000233	CbGpPWpGaD
Sulindac—PTGS2—Disease—NPPA—dilated cardiomyopathy	6.67e-05	0.00023	CbGpPWpGaD
Sulindac—PTGS2—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	6.66e-05	0.00023	CbGpPWpGaD
Sulindac—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—dilated cardiomyopathy	6.65e-05	0.00023	CbGpPWpGaD
Sulindac—PTGS2—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	6.48e-05	0.000224	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—RAC1—dilated cardiomyopathy	6.48e-05	0.000224	CbGpPWpGaD
Sulindac—PTGS2—Disease—PSEN2—dilated cardiomyopathy	6.46e-05	0.000223	CbGpPWpGaD
Sulindac—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—dilated cardiomyopathy	6.34e-05	0.000219	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—CXCR3—dilated cardiomyopathy	6.28e-05	0.000217	CbGpPWpGaD
Sulindac—MAPK3—Immune System—CD36—dilated cardiomyopathy	6.28e-05	0.000217	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—AGT—dilated cardiomyopathy	6.19e-05	0.000214	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—SDHA—dilated cardiomyopathy	6.18e-05	0.000213	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—ADRB1—dilated cardiomyopathy	6.08e-05	0.00021	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—EGFR—dilated cardiomyopathy	6.06e-05	0.000209	CbGpPWpGaD
Sulindac—SLC22A6—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	6e-05	0.000207	CbGpPWpGaD
Sulindac—MAPK3—Immune System—RAC1—dilated cardiomyopathy	5.92e-05	0.000204	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	5.91e-05	0.000204	CbGpPWpGaD
Sulindac—PTGS2—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	5.84e-05	0.000202	CbGpPWpGaD
Sulindac—ALB—Hemostasis—CD36—dilated cardiomyopathy	5.76e-05	0.000199	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	5.75e-05	0.000199	CbGpPWpGaD
Sulindac—MAPK3—Disease—RAC1—dilated cardiomyopathy	5.46e-05	0.000189	CbGpPWpGaD
Sulindac—ALB—Hemostasis—RAC1—dilated cardiomyopathy	5.43e-05	0.000188	CbGpPWpGaD
Sulindac—ALB—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	5.39e-05	0.000186	CbGpPWpGaD
Sulindac—ALB—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	5.25e-05	0.000181	CbGpPWpGaD
Sulindac—MAPK3—Developmental Biology—EGFR—dilated cardiomyopathy	5.23e-05	0.000181	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—AGTR1—dilated cardiomyopathy	5.19e-05	0.000179	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	5.18e-05	0.000179	CbGpPWpGaD
Sulindac—MAPK3—Developmental Biology—TNF—dilated cardiomyopathy	4.98e-05	0.000172	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—ADRB2—dilated cardiomyopathy	4.93e-05	0.00017	CbGpPWpGaD
Sulindac—ALB—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	4.72e-05	0.000163	CbGpPWpGaD
Sulindac—MAPK3—Innate Immune System—EGFR—dilated cardiomyopathy	4.62e-05	0.00016	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—RAF1—dilated cardiomyopathy	4.29e-05	0.000148	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	4.23e-05	0.000146	CbGpPWpGaD
Sulindac—MAPK3—Immune System—RAF1—dilated cardiomyopathy	3.92e-05	0.000136	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—RAC1—dilated cardiomyopathy	3.83e-05	0.000132	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	3.77e-05	0.00013	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—GPX1—dilated cardiomyopathy	3.73e-05	0.000129	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	3.67e-05	0.000127	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—AGT—dilated cardiomyopathy	3.66e-05	0.000126	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—CD36—dilated cardiomyopathy	3.64e-05	0.000126	CbGpPWpGaD
Sulindac—MAPK3—Disease—RAF1—dilated cardiomyopathy	3.62e-05	0.000125	CbGpPWpGaD
Sulindac—ALB—Hemostasis—RAF1—dilated cardiomyopathy	3.6e-05	0.000124	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	3.3e-05	0.000114	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—AGT—dilated cardiomyopathy	3.27e-05	0.000113	CbGpPWpGaD
Sulindac—PTGS2—Disease—RAC1—dilated cardiomyopathy	3.25e-05	0.000112	CbGpPWpGaD
Sulindac—ALB—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	3.12e-05	0.000108	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—GPX1—dilated cardiomyopathy	2.96e-05	0.000102	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—EGFR—dilated cardiomyopathy	2.94e-05	0.000102	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—CD36—dilated cardiomyopathy	2.89e-05	9.97e-05	CbGpPWpGaD
Sulindac—MAPK3—Immune System—EGFR—dilated cardiomyopathy	2.69e-05	9.29e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—GPX1—dilated cardiomyopathy	2.63e-05	9.09e-05	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—AGT—dilated cardiomyopathy	2.6e-05	8.98e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—CD36—dilated cardiomyopathy	2.56e-05	8.85e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—RAF1—dilated cardiomyopathy	2.54e-05	8.76e-05	CbGpPWpGaD
Sulindac—MAPK3—Disease—EGFR—dilated cardiomyopathy	2.48e-05	8.58e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—GPX1—dilated cardiomyopathy	2.4e-05	8.28e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—CD36—dilated cardiomyopathy	2.34e-05	8.07e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—AGT—dilated cardiomyopathy	2.31e-05	7.97e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—RAF1—dilated cardiomyopathy	2.15e-05	7.44e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—AGT—dilated cardiomyopathy	2.1e-05	7.26e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—EGFR—dilated cardiomyopathy	1.74e-05	6.01e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—GPX1—dilated cardiomyopathy	1.68e-05	5.79e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—CD36—dilated cardiomyopathy	1.63e-05	5.64e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—EGFR—dilated cardiomyopathy	1.48e-05	5.1e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—AGT—dilated cardiomyopathy	1.47e-05	5.08e-05	CbGpPWpGaD
